| Parkin interacts with Klokin1 for mitochondrial import and maintenance of membrane potential. Kuroda Y., Sako W., Goto S., Sawada T., Uchida D., Izumi Y., Takahashi T., Kagawa N., Matsumoto M., Matsumoto M. et al.
Hum. Mol. Genet. 21:991-1003(2012) · Mapped (28) |
| PPARalpha deficiency augments a ketogenic diet-induced circadian PAI-1 expression possibly through PPARgamma activation in the liver. Oishi K., Uchida D., Ohkura N., Horie S.
Biochem. Biophys. Res. Commun. 401:313-318(2010) · Mapped (16) |
| Vesnarinone downregulates CXCR4 expression via upregulation of Kruppel-like factor 2 in oral cancer cells. Uchida D., Onoue T., Begum N.M., Kuribayashi N., Tomizuka Y., Tamatani T., Nagai H., Miyamoto Y.
Mol. Cancer 8:62-62(2009) · Mapped (4) |
| Hypoxia enhances CXCR4 expression by activating HIF-1 in oral squamous cell carcinoma. Ishikawa T., Nakashiro K., Klosek S.K., Goda H., Hara S., Uchida D., Hamakawa H.
Oncol. Rep. 21:707-712(2009) · Mapped (11) |
| PERIOD2 is a circadian negative regulator of PAI-1 gene expression in mice. Oishi K., Miyazaki K., Uchida D., Ohkura N., Wakabayashi M., Doi R., Matsuda J., Ishida N.
J. Mol. Cell. Cardiol. 46:545-552(2009) · Mapped (11) |
| Circadian expression of FGF21 is induced by PPARalpha activation in the mouse liver. Oishi K., Uchida D., Ishida N.
FEBS Lett. 582:3639-3642(2008) · Mapped (2) |
| Involvement of an autocrine stromal cell derived factor-1/CXCR4 system on the distant metastasis of human oral squamous cell carcinoma. Uchida D., Onoue T., Tomizuka Y., Begum N.M., Miwa Y., Yoshida H., Sato M.
Mol. Cancer Res. 5:685-694(2007) · Mapped (4) |
| Oncogenic mutation of the p53 gene derived from head and neck cancer prevents cells from undergoing apoptosis after DNA damage. Kawamata H., Omotehara F., Nakashiro K., Uchida D., Shinagawa Y., Tachibana M., Imai Y., Fujimori T.
Int. J. Oncol. 30:1089-1097(2007) · Mapped (32) |
| Development of autoimmunity against transcriptionally unrepressed target antigen in the thymus of Aire-deficient mice. Kuroda N., Mitani T., Takeda N., Ishimaru N., Arakaki R., Hayashi Y., Bando Y., Izumi K., Takahashi T., Nomura T. et al.
J. Immunol. 174:1862-1870(2005) · Mapped (7) |
| Acquisition of lymph node, but not distant metastatic potentials, by the overexpression of CXCR4 in human oral squamous cell carcinoma. Uchida D., Begum N.M., Tomizuka Y., Bando T., Almofti A., Yoshida H., Sato M.
Lab. Invest. 84:1538-1546(2004) · Mapped (2) |
| Frequent downregulation of 14-3-3 sigma protein and hypermethylation of 14-3-3 sigma gene in salivary gland adenoid cystic carcinoma. Uchida D., Begum N.M., Almofti A., Kawamata H., Yoshida H., Sato M.
Br. J. Cancer 91:1131-1138(2004) · Mapped (1) |
| The clinicopathological significance of the expression of CXCR4 protein in oral squamous cell carcinoma. Almofti A., Uchida D., Begum N.M., Tomizuka Y., Iga H., Yoshida H., Sato M.
Int. J. Oncol. 25:65-71(2004) · Mapped (2) |
| Possible role of stromal-cell-derived factor-1/CXCR4 signaling on lymph node metastasis of oral squamous cell carcinoma. Uchida D., Begum N.M., Almofti A., Nakashiro K., Kawamata H., Tateishi Y., Hamakawa H., Yoshida H., Sato M.
Exp. Cell Res. 290:289-302(2003) · Mapped (2) |
| Posttranscriptional regulation of TSC-22 (TGF-beta-stimulated clone-22) gene by TGF-beta 1. Uchida D., Omotehara F., Nakashiro K., Tateishi Y., Hino S., Begum N.M., Fujimori T., Kawamata H.
Biochem. Biophys. Res. Commun. 305:846-854(2003) · Mapped (2) |
| Mechanism of growth promoting activity of epiregulin in primary cultures of rat hepatocytes. Komurasaki T., Toyoda H., Uchida D., Nemoto N.
Growth Factors 20:61-69(2002) · Mapped (2) |
| Leucine zipper structure of TSC-22 (TGF-beta stimulated clone-22) markedly inhibits the anchorage-independent growth of salivary gland cancer cells. Hino S., Kawamata H., Omotehara F., Uchida D., Begum N.M., Yoshida H., Sato M., Fujimori T.
Oncol. Rep. 9:371-374(2002) · Mapped (2) |
| Expression of peroxisome proliferator-activated receptor gamma and the growth inhibitory effect of its synthetic ligands in human salivary gland cancer cell lines. Begum N.M., Nakashiro K., Kawamata H., Uchida D., Shintani S., Ikawa Y., Sato M., Hamakawa H.
Int. J. Oncol. 20:599-605(2002) · Mapped (9) |
| Essential role of nuclear factor (NF)-kappaB-inducing kinase and inhibitor of kappaB (IkappaB) kinase alpha in NF-kappaB activation through lymphotoxin beta receptor, but not through tumor necrosis factor receptor I. Matsushima A., Kaisho T., Rennert P.D., Nakano H., Kurosawa K., Uchida D., Takeda K., Akira S., Matsumoto M.
J. Exp. Med. 193:631-636(2001) · Mapped (12) |
| Abnormal immune function of hemopoietic cells from alymphoplasia (aly) mice, a natural strain with mutant NF-kappa B-inducing kinase. Yamada T., Mitani T., Yorita K., Uchida D., Matsushima A., Iwamasa K., Fujita S., Matsumoto M.
J. Immunol. 165:804-812(2000) · Mapped (3) |
| Epiregulin binds to epidermal growth factor receptor and ErbB-4 and induces tyrosine phosphorylation of epidermal growth factor receptor, ErbB-2, ErbB-3 and ErbB-4. Komurasaki T., Toyoda H., Uchida D., Morimoto S.
Oncogene 15:2841-2848(1997) · UniProtKB (3) · Mapped (1) |
| Distribution of mRNA for human epiregulin, a differentially expressed member of the epidermal growth factor family. Toyoda H., Komurasaki T., Uchida D., Morimoto S.
Biochem. J. 326:69-75(1997) · UniProtKB (1) · Mapped (1) |
| Ontogeny of pituitary adenylate cyclase activating polypeptide and its receptor mRNA in the mouse brain. Shuto Y., Uchida D., Onda H., Arimura A.
Regul. Pept. 67:79-83(1996) · Mapped (12) |
| Epiregulin, a novel epidermal growth factor with mitogenic activity for rat primary hepatocytes. Toyoda H., Komurasaki T., Uchida D., Takayama Y., Isobe T., Okuyama T., Hanada K.
J. Biol. Chem. 270:7495-7500(1995) · UniProtKB (1) |
